PGP and B-cell chronic lymphocytic leukemia: This may be connected with higher activity of P-gp in patients with this ABCB1 genetic polymorphism, that was previously reported in patients with B cell chronic lymphocytic leukemia, and what comes along with the increased active transport of drugs out of cells, suggesting and supporting the thesis of a protective role of the C3435C variant [12].